Conmed (CNMD) Financial Statements

205 Followers

Conmed Financial Overview

Conmed's market cap is currently $1.14B. The company's EPS TTM is $; its P/E ratio is 26.78; and it has a dividend yield of 2.02%. Conmed is scheduled to report earnings on April 29, 2026, and the estimated EPS forecast is $0.82. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 1.37B	$ 1.31B	$ 1.24B	$ 1.05B	$ 1.01B
Gross Profit	$ 750.48M	$ 733.03M	$ 676.25M	$ 571.25M	$ 568.04M
Operating Income	$ 102.62M	$ 200.33M	$ 120.60M	$ 70.05M	$ 109.72M
EBITDA	$ 176.49M	$ 272.18M	$ 192.48M	$ 7.80M	$ 179.33M
Net Income	$ 47.05M	$ 132.42M	$ 64.46M	$ -80.58M	$ 62.54M
Balance Sheet
Cash & Short-Term Investments	$ 40.82M	$ 24.46M	$ 24.30M	$ 28.94M	$ 20.85M
Total Assets	$ 2.33B	$ 2.31B	$ 2.30B	$ 2.30B	$ 1.77B
Total Debt	$ 834.94M	$ 905.78M	$ 991.25M	$ 1.05B	$ 684.66M
Net Debt	$ 794.13M	$ 881.32M	$ 966.96M	$ 1.03B	$ 663.81M
Total Liabilities	$ 1.29B	$ 1.34B	$ 1.47B	$ 1.55B	$ 980.58M
Stockholders' Equity	$ 1.03B	$ 962.68M	$ 834.22M	$ 745.54M	$ 785.43M
Cash Flow
Free Cash Flow	$ 150.88M	$ 153.88M	$ 106.32M	$ 11.58M	$ 96.90M
Operating Cash Flow	$ 170.69M	$ 166.97M	$ 125.35M	$ 33.37M	$ 111.77M
Investing Cash Flow	$ -20.96M	$ -13.08M	$ -20.03M	$ -249.53M	$ -14.87M
Financing Cash Flow	$ -135.82M	$ -151.00M	$ -110.43M	$ 225.00M	$ -101.55M

Currency in USD

Conmed Earnings and Revenue History

Income Statement >

Conmed Debt to Assets

Balance Sheet >

Conmed Cash Flow

Cash Flow >

Conmed Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >